Ontogeny of 2-[125I]iodomelatonin binding sites in the chicken (Gallus domesticus) kidney and spleen

Can J Physiol Pharmacol. 1995 Jun;73(6):685-92. doi: 10.1139/y95-088.

Abstract

To understand the possible role of melatonin receptors in the development of renal and immune functions, age-related variations of 2-[125I]iodomelatonin binding sites in the chicken kidney and spleen were investigated by radioreceptor assay. Chickens at embryonic day 20, as well as 2 days, 9 days, 2 weeks, 6 weeks, 12 weeks, and 16 weeks after hatching, were kept under a 12 h light:12 h dark photoperiod and killed at the middle of the light period. Binding sites for 2-[125I]iodomelatonin in membrane preparations of the chicken kidney and spleen were present on embryonic day 20. The maximum binding densities (Bmax) in the kidney increased to a peak between 9 days and 2 weeks of age, then progressively decreased. Bmax values of 2-[125I]iodomelatonin binding sites in the chicken spleen were lower than in the kidney. The peak density in the chicken spleen was recorded at day 2 after hatching and decreased significantly after 6 weeks of age. There were no significant differences in binding affinities (Kd) in kidney and spleen of chicken in the different age groups studied. The unity of Hill coefficients of 2-[125I]iodomelatonin binding sites of the chicken kidney and spleen in all age groups tested suggested that only a single class of binding sites was present in these tissues during development. It is proposed that the developmental changes in 2-[125I]iodomelatonin binding sites in the chicken kidney and spleen may be pertinent to the development of diurnal rhythms of kidney functions and the post-pubertal decline in immune functions of the chicken.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Binding Sites*
  • Chickens
  • Dose-Response Relationship, Drug
  • Female
  • Kidney / metabolism*
  • Kinetics
  • Male
  • Melatonin / pharmacology*
  • Radioligand Assay
  • Spleen / metabolism*

Substances

  • Melatonin